Medical Cannabis is no longer a Narcotic in Germany: What impact does the new legislation have on the market and the involved stakeholders?

With the new CanG, Germany has removed medical cannabis from the
narcotics list. Doctors can now prescribe cannabis to patients
without extensive bureaucratic hurdles, and at the same time, the
cultivation of medical cannabis in Germany is permitted. What
impact does this have on the market regarding prescription
numbers for private and insured patients? How do patients benefit
from this? What do doctors and pharmacies say about the new
legislation?

Moderator



Garvin Hirt



Speakers



Leif Burmeister


Christiane Neubaur


Marcus Reussmann


Nicole Perenyi